• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of July 25, 2012

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-1701-12
Classification Class II
Code Info 3910082101; 3910082598; 3910082906; 3910085911; 3910086807; 3910081900; 3910081503; 3910081868; 3910082275; 3910082774; 3910083156; 3910083903; 3910084951; 3910085815; 3910086223; 3910080955; 3910081305; 3910081712; 3910082232; 3910082762; 3910083137; 3910083887; 3910084221; 3910084617; 3910084939; 3910085447; 3910085791; 3910086679; 3910047776; 3910043408; 3910042108; 3910038442; 3910037785; 3910037362; 3910036416; 3910035164; 3910034679; 3910032818; 3910029232; 3910028845; 3910027896; 3910027430; 3910026492; 3910024632; 3910023541; 3910022087; 3910021589; 3910020014; 3910018908; 3910018439; 3910017446; 3910017013; 3910015987; 3910015521; 3910014524; 3910014092; 3910013152; 3910012673; 3910011604; 3910010577; 3910010196; 3910009286;
Product Distributed Qty 62
Reason For Recall Blood products, collected from a donor whose routine physical examination was inadequately performed, were distributed.

Event Detail

Event Id 55441
Product Type Biologics
Status Terminated
Recalling Firm Talecris Plasma Resources, Inc.
City N Las Vegas
State NV
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-03-17
Initial Firm Notification of Consignee or Public FAX
Distribution Pattern CA. Name and address of consignee involved: Talecris Biotherapeutics, Inc. (TBI), 8368 US 70 Business Highway West, Clayton, NC 27520
-
-